Delivery Order SPE2DR25D1100-SPE2DR26FCQ0E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a pharmaceutical product, valued at $1,385.52. The order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, was competitively awarded without a set-aside designation under a firm fixed-price contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's ability to compete...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30-unit packages. This $4,156.56 firm fixed price contract, with an ultimate completion date of November 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will be...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, is scheduled for completion by September 9, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was competitively made with no set-aside designation, reflecting the open competition process typical of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, valued at $1,385.52. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52 with completion scheduled for September 23, 2025, represents a non-competitive award issued under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg with a firm fixed price ceiling value of $1,385.52. This non-set-aside delivery order was awarded on July 31, 2025, and carries an ultimate completion date of August 21, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office and serves as a major pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,855.20 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 1, 2025, with a completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This $8,760.78 firm fixed-price delivery order, which will be completed by December 5, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,156.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-unit package) on September 2, 2025, with an ultimate completion date of September 23, 2025. The award, which is not set-aside and was competitively awarded, directs fulfillment from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical transaction within AmerisourceBergen's...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCQ0EDelivery Order
The Defense Logistics Agency awarded a $1,460.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with a completion deadline of December 10, 2025. This non-set-aside award was issued on November 18, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. This award is a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military and veteran healthcare systems. The IDC vehicle enables the contractor to fulfill medical supply needs across multiple therapeutic domains for defense health programs worldwide, demonstrating the company's established capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/18/25 |